669 related articles for article (PubMed ID: 11350170)
1. Structure and binding determinants of the recombinant kringle-2 domain of human plasminogen to an internal peptide from a group A Streptococcal surface protein.
Rios-Steiner JL; Schenone M; Mochalkin I; Tulinsky A; Castellino FJ
J Mol Biol; 2001 May; 308(4):705-19. PubMed ID: 11350170
[TBL] [Abstract][Full Text] [Related]
2. Solution structure of the complex of VEK-30 and plasminogen kringle 2.
Wang M; Zajicek J; Geiger JH; Prorok M; Castellino FJ
J Struct Biol; 2010 Mar; 169(3):349-59. PubMed ID: 19800007
[TBL] [Abstract][Full Text] [Related]
3. Structure and ligand binding determinants of the recombinant kringle 5 domain of human plasminogen.
Chang Y; Mochalkin I; McCance SG; Cheng B; Tulinsky A; Castellino FJ
Biochemistry; 1998 Mar; 37(10):3258-71. PubMed ID: 9521645
[TBL] [Abstract][Full Text] [Related]
4. Ligand preferences of kringle 2 and homologous domains of human plasminogen: canvassing weak, intermediate, and high-affinity binding sites by 1H-NMR.
Marti DN; Hu CK; An SS; von Haller P; Schaller J; Llinás M
Biochemistry; 1997 Sep; 36(39):11591-604. PubMed ID: 9305949
[TBL] [Abstract][Full Text] [Related]
5. Crystal structures of the recombinant kringle 1 domain of human plasminogen in complexes with the ligands epsilon-aminocaproic acid and trans-4-(aminomethyl)cyclohexane-1-carboxylic Acid.
Mathews II; Vanderhoff-Hanaver P; Castellino FJ; Tulinsky A
Biochemistry; 1996 Feb; 35(8):2567-76. PubMed ID: 8611560
[TBL] [Abstract][Full Text] [Related]
6. Recombinant kringle IV-10 modules of human apolipoprotein(a): structure, ligand binding modes, and biological relevance.
Mochalkin I; Cheng B; Klezovitch O; Scanu AM; Tulinsky A
Biochemistry; 1999 Feb; 38(7):1990-8. PubMed ID: 10026282
[TBL] [Abstract][Full Text] [Related]
7. Structural/functional characterization of the alpha 2-plasmin inhibitor C-terminal peptide.
Frank PS; Douglas JT; Locher M; Llinás M; Schaller J
Biochemistry; 2003 Feb; 42(4):1078-85. PubMed ID: 12549929
[TBL] [Abstract][Full Text] [Related]
8. X-ray crystallographic structure of the angiogenesis inhibitor, angiostatin, bound to a peptide from the group A streptococcal surface protein PAM.
Cnudde SE; Prorok M; Castellino FJ; Geiger JH
Biochemistry; 2006 Sep; 45(37):11052-60. PubMed ID: 16964966
[TBL] [Abstract][Full Text] [Related]
9. The X-ray crystallographic structure of the angiogenesis inhibitor angiostatin.
Abad MC; Arni RK; Grella DK; Castellino FJ; Tulinsky A; Geiger JH
J Mol Biol; 2002 May; 318(4):1009-17. PubMed ID: 12054798
[TBL] [Abstract][Full Text] [Related]
10. Structure of the lysine-fibrin binding subsite of human plasminogen kringle 4.
Mulichak AM; Tulinsky A
Blood Coagul Fibrinolysis; 1990 Dec; 1(6):673-9. PubMed ID: 1966798
[TBL] [Abstract][Full Text] [Related]
11. Crystal structures of apolipoprotein(a) kringle IV37 free and complexed with 6-aminohexanoic acid and with p-aminomethylbenzoic acid: existence of novel and expected binding modes.
Mikol V; LoGrasso PV; Boettcher BR
J Mol Biol; 1996 Mar; 256(4):751-61. PubMed ID: 8642595
[TBL] [Abstract][Full Text] [Related]
12. Enhancement through mutagenesis of the binding of the isolated kringle 2 domain of human plasminogen to omega-amino acid ligands and to an internal sequence of a Streptococcal surface protein.
Nilsen SL; Prorok M; Castellino FJ
J Biol Chem; 1999 Aug; 274(32):22380-6. PubMed ID: 10428809
[TBL] [Abstract][Full Text] [Related]
13. Human plasminogen kringle 3: solution structure, functional insights, phylogenetic landscape.
Christen MT; Frank P; Schaller J; Llinás M
Biochemistry; 2010 Aug; 49(33):7131-50. PubMed ID: 20617841
[TBL] [Abstract][Full Text] [Related]
14. Solution structure and functional characterization of human plasminogen kringle 5.
Battistel MD; Grishaev A; An SS; Castellino FJ; Llinás M
Biochemistry; 2009 Nov; 48(43):10208-19. PubMed ID: 19821587
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of the soluble domain of the major anaerobically induced outer membrane protein (AniA) from pathogenic Neisseria: a new class of copper-containing nitrite reductases.
Boulanger MJ; Murphy ME
J Mol Biol; 2002 Feb; 315(5):1111-27. PubMed ID: 11827480
[TBL] [Abstract][Full Text] [Related]
16. Thermodynamics of ligand binding and denaturation for His64 mutants of tissue plasminogen activator kringle-2 domain.
Kelley RF; DeVos AM; Cleary S
Proteins; 1991; 11(1):35-44. PubMed ID: 1961700
[TBL] [Abstract][Full Text] [Related]
17. Recombinant gene expression and 1H NMR characteristics of the kringle (2 + 3) supermodule: spectroscopic/functional individuality of plasminogen kringle domains.
Söhndel S; Hu CK; Marti D; Affolter M; Schaller J; Llinás M; Rickli EE
Biochemistry; 1996 Feb; 35(7):2357-64. PubMed ID: 8652577
[TBL] [Abstract][Full Text] [Related]
18. The col-1 module of human matrix metalloproteinase-2 (MMP-2): structural/functional relatedness between gelatin-binding fibronectin type II modules and lysine-binding kringle domains.
Gehrmann M; Briknarová K; Bányai L; Patthy L; Llinás M
Biol Chem; 2002 Jan; 383(1):137-48. PubMed ID: 11928808
[TBL] [Abstract][Full Text] [Related]
19. The lack of binding of VEK-30, an internal peptide from the group A streptococcal M-like protein, PAM, to murine plasminogen is due to two amino acid replacements in the plasminogen kringle-2 domain.
Fu Q; Figuera-Losada M; Ploplis VA; Cnudde S; Geiger JH; Prorok M; Castellino FJ
J Biol Chem; 2008 Jan; 283(3):1580-1587. PubMed ID: 18039665
[TBL] [Abstract][Full Text] [Related]
20. Interactions between canine plasminogen and 8-anilino-1-naphthalene sulfonate: structural insights from a fluorescent probe.
Carter DM; Kornblatt JA
Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51 Suppl():OL755-65. PubMed ID: 16171575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
